Table 4.
DE SLP; Mitral valve opening speed (cm/s) [median (minimum-maximum)] after administration of metoclopramide and ondansetron in donkeys at different time points.
| Treatment | Time after administration (min) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| T0 | T15 | T30 | T60 | T90 | T120 | T180 | T240 | T300 | T360 | |
| Placebo | 9.2 (5.3–11.6) | 9.1 (5.3–11.6) | 9.5 (5.3–11.6) | 9.4 (5.3–11.6)a | 9.5 (5.4–1.6) | 9.1 (5.5–11.6)a | 9.3 (5.3–11.6) | 9.2 (5.3–11.6) | 9.1 (5.3–11.6)a | 9.5 (5.3–11.9) |
| Metoclopramide 0.25 mg Kg−1 (n = 10) | 9.1 (5.3–11.6) | 10 (8.1–13.9)* | 11.6 (6.7–13.4)* | 10 (9.3–13)*a | 10.6 (9–3.1)* | 11.2 (10–4.9)*b | 11.1 (9.6–2.7)* | 11.4 (4.8–12.2)* | 12 (9.2–16.5)*b | 9.2 (6.7–12.6)* |
| Ondansetron 0.15 mg Kg−1 (n = 10) | 9.5 (5.3–11.6) | 10.2 (8.7–13.4) | 10.4 (7.2–11.5) | 11.6 (10–2.8)ab | 10 (9.3–11.4) | 10.2 (7.6–11.9)a | 11.5 (10.2–12) | 10.6 (8.4–12.6) | 10.9 (10–12.2)ab | 10.6 (7.2–12.8) |
a,b Variables with different superscript letters within the same time point significantly differ at p < 0.05.
Variables with (*) significantly differ at p < 0.05 over time.